Report: Japan’s PMDA had shortest review times for new drugs, half of drugs submitted to US first
Regulatory NewsFerdous Al-Faruque
European Medicines Agency (EMA)GlobalPharmaceuticalsPharmaceuticals and Medical Devices Agency (PMDA)Regulatory Intelligence/PolicySwissmedicUS Food and Drug Administration (FDA)